EC Number | Application | Comment | Organism |
---|---|---|---|
5.4.2.2 | drug development | the activity of the PGM gene of Streptococcus iniae is linked to a variety of structural and functional phenotypes that translate to dramatically decreased virulence in a model of fish meningoencephalitis | Streptococcus iniae |
EC Number | Cloned (Comment) | Organism |
---|---|---|
5.4.2.2 | expression in Escherichia coli | Streptococcus iniae |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
5.4.2.2 | Streptococcus iniae | - |
- |
- |
5.4.2.2 | Streptococcus iniae K288 | - |
- |
- |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
5.4.2.2 | additional information | - |
PGM activity decreases more than fivefold in mutant TnM2 compared to the wild type strain | Streptococcus iniae |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
5.4.2.2 | D-glucose-1-phosphate | - |
Streptococcus iniae | glucose-6-phosphate | - |
? | |
5.4.2.2 | D-glucose-1-phosphate | - |
Streptococcus iniae K288 | glucose-6-phosphate | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
5.4.2.2 | PGM | - |
Streptococcus iniae |